161 related articles for article (PubMed ID: 8784014)
1. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study.
Lafitte JJ; Ribet ME; Prévost BM; Gosselin BH; Copin MC; Brichet AH
Ann Thorac Surg; 1996 Sep; 62(3):830-4. PubMed ID: 8784014
[TBL] [Abstract][Full Text] [Related]
2. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer.
Gould PM; Bonner JA; Sawyer TE; Deschamps C; Lange CM; Li H
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):91-5. PubMed ID: 10477011
[TBL] [Abstract][Full Text] [Related]
4. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
Bryant AS; Pereira SJ; Miller DL; Cerfolio RJ
Ann Thorac Surg; 2006 Nov; 82(5):1808-13; discussion 1813-4. PubMed ID: 17062253
[TBL] [Abstract][Full Text] [Related]
5. [Results of surgical treatment of stage I non-small cell lung cancer].
Zhang L
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):209-11. PubMed ID: 8261868
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Prognosis After Segmentectomy for cT1 N0 M0 Non-Small Cell Lung Cancer.
Nomori H; Mori T; Shiraishi A; Fujino K; Sato Y; Ito T; Suzuki M
Ann Thorac Surg; 2019 May; 107(5):1500-1506. PubMed ID: 30579848
[TBL] [Abstract][Full Text] [Related]
7. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.
Battafarano RJ; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
Ann Thorac Surg; 2002 Oct; 74(4):988-93; discussion 993-4. PubMed ID: 12400733
[TBL] [Abstract][Full Text] [Related]
9. Stage II esophageal carcinoma: the significance of T and N.
Killinger WA; Rice TW; Adelstein DJ; Medendorp SV; Zuccaro G; Kirby TJ; Goldblum JR
J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
12. [Lung cancer--hopelessness in inoperability? A 10-year follow-up].
Schwegler N
Strahlenther Onkol; 1997 Jul; 173(7):352-61. PubMed ID: 9265257
[TBL] [Abstract][Full Text] [Related]
13. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
14. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
15. Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG.
Perez CA; Bauer M; Emami BN; Byhardt R; Brady LW; Doggett RL; Gardner P; Zinninger M
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1337-46. PubMed ID: 2848786
[TBL] [Abstract][Full Text] [Related]
16. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type.
Choi YS; Shim YM; Kim K; Kim J
J Korean Med Sci; 2004 Oct; 19(5):674-6. PubMed ID: 15483342
[TBL] [Abstract][Full Text] [Related]
17. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
18. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
19. Incidence of local recurrence and second primary tumors in resected stage I lung cancer.
Martini N; Bains MS; Burt ME; Zakowski MF; McCormack P; Rusch VW; Ginsberg RJ
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):120-9. PubMed ID: 7815787
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of sleeve lobectomy for lung cancer.
Tronc F; Grégoire J; Rouleau J; Deslauriers J
Eur J Cardiothorac Surg; 2000 May; 17(5):550-6. PubMed ID: 10814918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
